Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
BIOINCEPT LLC See All Filings	D	2020-10-20 10:51:12 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0001401750 Filed Document 0001192482-20-000778 Exclusions or Exemptions 506c Accepted Date 2020-10-20 10:51:12 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Equity
BIOINCEPT LLC See All Filings	D	2019-03-07 07:32:36 UTC
Amount To Be Raised $8,000,000 Associated Brokers / Dealers N/A CIK Number 0001401750 Filed Document 0001192482-19-000121 Exclusions or Exemptions 506b Accepted Date 2019-03-07 07:32:36 UTC Type of Offering D Industry Biotechnology Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Equity
BIOINCEPT LLC See All Filings	D/A	2016-12-01 16:52:59 UTC
Amount To Be Raised $7,284,757 Associated Brokers / Dealers N/A CIK Number 0001401750 Filed Document 0001192482-16-000761 Exclusions or Exemptions 506b Accepted Date 2016-12-01 16:52:59 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
BIOINCEPT LLC See All Filings	D	2016-09-02 11:33:20 UTC
Amount To Be Raised $13,533,445 Associated Brokers / Dealers N/A CIK Number 0001401750 Filed Document 0001192482-16-000705 Exclusions or Exemptions 506b Accepted Date 2016-09-02 11:33:20 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity
BIOINCEPT LLC See All Filings	D/A	2014-04-25 00:00:00 UTC
Amount To Be Raised $6,500,000 Associated Brokers / Dealers N/A CIK Number 0001401750 Filed Document 0001192482-14-000071 Exclusions or Exemptions 506c Accepted Date 2014-04-25 00:00:00 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business NEW JERSEY Revenue or Assets Decline to Disclose Type of Security Equity